ORIGINAL ARTICLE
Prognostic impact of spread through air spaces and its association with KRAS mutation and histopathologic factors in resected colorectal lung metastases
More details
Hide details
1
Department of Pathology Clinic, Kartal Dr. Lutfi Kirdar Education and Research Hospital, Istanbul, Turkey
2
Department of Pathology Clinic, Istanbul Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey
3
Department of Thoracic Surgery Clinic, Kartal Dr. Lutfi Kirdar Education and Research Hospital, Istanbul, Turkey
Submission date: 2025-11-11
Final revision date: 2026-01-18
Acceptance date: 2026-01-20
Publication date: 2026-06-08
Corresponding author
Gonca Gül Geçmen
Kartal Dr. Lutfi Kirdar Education and Research Hospital, Department of Pathologic Clinic
Pol J Pathol 2026;77(1):1-11
KEYWORDS
TOPICS
ABSTRACT
Spread through air spaces (STAS) represents an independent prognostic factor for poor overall survival (OS) in patients with colorectal carcinoma who underwent pulmonary metastasectomy. This study aims to evaluate the prognostic impact of STAS and explore its associations with histopathologic features and KRAS mutation status/subtypes.We retrospectively analyzed 61 consecutive patients with colorectal cancer (CRC) who underwent pulmonary metastasectomy at a single tertiary center (May 2016 – July 2024). Histopathologic review assessed STAS and other histopathologic features. KRAS mutations were tested using a real-time polymerase chain reaction assay detecting 19 variants (codons 12, 13, 59, 61, 117, 146).
Spread through air spaces was present in 37/61 cases (60.7%). Median OS was 1702 days (95% CI: 1495–NA) in STAS-negative and 1288 days (95% CI: 523–NA) in STAS-positive patients (log-rank p = 0.041). In univariable analysis, STAS remained an independent predictor of poorer OS in multivariable modeling (hazard ratio: 2.37; 95% CI: 1.17–4.80; p = 0.017). KRAS mutations (present in 44.3% of tested cases; common subtypes G12V and G12D) showed no significant association with STAS (p = 0.34) or with OS.
Spread through air spaces is an independent poor prognostic factor in resected CRC pulmonary metastases, whereas KRAS mutation status and subtypes were not prognostic in this cohort.
REFERENCES (27)
1.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2.
Parnaby CN, Bailey W, Balasingam A, Beckert L, Eglinton T, Fife J, et al. Pulmonary staging in colorectal cancer: a review. Colorectal Dis 2012; 14: 660-670.
3.
Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut 2010; 59: 1383-1388.
4.
Iida T, Nomori H, Shiba M, Nakajima J, Okumura S, Horio H, et al. Metastatic Lung Tumour Study Group of Japan. Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retro- spective analysis. Ann Surg 2013; 257: 1059-1064.
5.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
6.
Kadota K, Nitadori JI, Sima CS, Ujiie H, Rizk NP, Jones DR, et al. Tumour spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage i lung adenocarcinomas. J Thorac Oncol 2015; 10: 806-814.
7.
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to The 2015 World Health Organization Classification of Tumours of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol 2015; 10: 1240-1242.
8.
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. WHO Panel. The 2015 World Health Organization Classification of Lung Tumours: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 2015; 10: 1243-1260.
9.
Meng M, Zhong K, Jiang T, Liu Z, Kwan HY, Su T. The current understanding on the impact of KRAS on colorectal cancer. Biomed Pharmacother 2021; 140: 111717.
10.
László L, Kurilla A, Takács T, Kudlik G, Koprivanacz K, Buday L, et al. Recent updates on the significance of KRAS mutations in colorectal cancer biology. Cells 2021; 10: 667.
11.
Ye J, Lin M, Zhang C, Zhu X, Li S, Liu H, et al. Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications. Biomed Rep 2020; 13: 43-48.
12.
Kang D, Li J, Li Y, Xu J, Yang J, Zhang Z. Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II/III colorectal cancer: a retrospective study and meta-analysis. PLoS One 2025; 20: e0320783.
13.
Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 2003; 126: 732-739.
14.
Cho S, Song IH, Yang HC, Jheon S. Prognostic factors of pulmonary metastasis from colorectal carcinoma. Interact Cardiovasc Thorac Surg 2013; 17: 303-307.
15.
Watanabe K, Nagai K, Kobayashi A, Sugito M, Saito N. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg 2009; 96: 1058-1065.
16.
Tsitsias T, Toufektzian L, Routledge T, Pilling J. Are there recognized prognostic factors for patients undergoing pulmonary metastasectomy for colorectal carcinoma? Interact Cardiovasc Thorac Surg 2016; 23: 962-969.
17.
Shalabi A, Shalabi SF, Graeter T, Welter S, Ehab A, Kuon J. Low rates of intrapulmonary local recurrence after laser metastasectomy: a single-center retrospective cohort study of colorectal cancer metastases. Cancers (Basel) 2025; 17: 683.
18.
Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur. J. Cardio Thorac Surg 2007; 31: 167-172.
19.
Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, et al. Histopathologic prognostic factors in resected colorectal lung metastases. Ann Thorac Surg 2005; 79: 278-282.
20.
Shirakusa T, Tsutsui M, Motonaga R, Ando K, Kusano T. Resection of metastatic lung tumour: the evaluation of histologic appearance in the lung. Am Surg 1988; 54: 655-658.
21.
Karjula T, Kemi N, Niskakangas A, Mustonen O, Puro I, Pohjanen VM, et al. The prognostic role of tumour budding and tumour-stroma ratio in pulmonary metastasis of colorectal carcinoma. Eur J Surg Oncol 2023; 49: 1298-1306.
22.
Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-339.
23.
Shiono S, Ishii G, Nagai K, Murata Y, Tsuta K, Nitadori J, et al. Immunohistochemical prognostic factors in resected colorectal lung metastases using tissue microarray analysis. Eur J Surg Oncol 2006; 32: 308-309.
24.
Zhang Y, Wu Z, Zhang B, Hu H, Zhang J, Chen Y, et al. Prognostic impact of high-risk factors and KRAS mutation in patients with stage II deficient mismatch repair colon cancer: a retrospective cohort study. Ann Transl Med 2022; 10: 702.
25.
Takeda-Miyata N, Konishi E, Tanaka T, Shimomura M, Tsunezuka H, Okada S, et al. Prognostic significance of spread through air spaces in pulmonary metastases from colorectal cancer. Lung Cancer 2020; 149: 61-67.
26.
Haj Khalaf MA, Sirbu H, Hartmann A, Agaimy A, Dudek W, Higaze M, et al. Spread through air spaces (STAS) in solitary pulmonary metastases from colorectal cancer (CRC). Thorac Cardiovasc Surg 2023; 71: 138-144.
27.
Castro PM, Rei J, Silva C, Miranda J, Guerra M. Spreading through air spaces and thinking about lung metastases. Port J Card Thorac Vasc Surg 2023; 30: 31-35.